Clinical Trial

MADRE (Mammograms Available Due to Research and Education)

Study acronym: MADRE
Recruiting
View on ClinicalTrials.gov →
Summary
The design builds on past studies by integrating social network analysis (SNA) and implementation science (IS) into a longitudinal randomized clinical trial (RCT). The investigator will compare the long-term effects of interventions by examining guideline-concordant initial and repeat Breast Cancer (BC) screening.
Protocol Amendment History 2 changes
notable Primary completion moved earlier: 2027-08-31 -> 2026-09-30 2026-07-31
minor Completion moved earlier: 2027-08-31 -> 2026-10-31 2026-07-31
Trial Details
NCT Number NCT05841355
Lead Sponsor University of Illinois at Chicago
Conditions Breast Cancer Screening
Enrollment 600 participants
Start Date 2023-03-14
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-30